OMER - Omeros Corporation
NASDAQ
->
Healthcare
->
Biotechnology
Seattle,
United States
Type: Equity
OMER price evolution
OMER
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2.12 | $1.83 | $7.11 | |
| Short term investments | $156.79 | $228.5 | $164.74 | |
| Net receivables | $35.64 | $8.08 | $7.64 | $8.1 |
| Inventory | ||||
| Total current assets | $164.92 | $202.93 | $280.96 | $217.9 |
| Long term investments | $1.05 | $1.05 | $1.05 | |
| Property, plant & equipment | $17.87 | $18.9 | $19.57 | $20.58 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $153.38 | $156.53 | $160.37 | |
| Total investments | $157.85 | $229.56 | $165.8 | |
| Total assets | $313.33 | $356.31 | $437.49 | $378.27 |
| Current liabilities | ||||
| Accounts payable | $7.72 | $6.5 | $6.18 | $7.71 |
| Deferred revenue | ||||
| Short long term debt | $25.01 | $24.47 | $13.74 | |
| Total current liabilities | $55.62 | $59.48 | $59.06 | $53.32 |
| Long term debt | $394.55 | $419.35 | $447.68 | $347.85 |
| Total noncurrent liabilities | $421.44 | $449.76 | $349.94 | |
| Total debt | $444.36 | $472.15 | $361.58 | |
| Total liabilities | $467.51 | $480.91 | $508.82 | $403.25 |
| Shareholders' equity | ||||
| Retained earnings | -$878.99 | -$846.75 | -$790.71 | -$753.53 |
| Other shareholder equity | ||||
| Total shareholder equity | -$124.6 | -$71.33 | -$24.98 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $7.11 | $11.01 | $100.81 | $10.5 |
| Short term investments | $164.74 | $183.91 | $56.46 | $124.45 |
| Net receivables | $8.1 | $242.02 | $38.16 | $3.84 |
| Inventory | $1.35 | |||
| Total current assets | $217.9 | $443.24 | $247.89 | $151.28 |
| Long term investments | $1.05 | $1.05 | $1.05 | $1.05 |
| Property, plant & equipment | $20.58 | $23.25 | $30.01 | $28.08 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $160.37 | $147.73 | $171.38 | $29.76 |
| Total investments | $165.8 | $184.96 | $57.51 | $125.51 |
| Total assets | $378.27 | $590.97 | $419.27 | $181.04 |
| Current liabilities | ||||
| Accounts payable | $7.71 | $5.99 | $13.4 | $4.2 |
| Deferred revenue | ||||
| Short long term debt | $13.74 | $98.69 | $5.25 | $3.78 |
| Total current liabilities | $53.32 | $136.38 | $51.79 | $36.74 |
| Long term debt | $347.85 | $346.49 | $342.58 | $265.06 |
| Total noncurrent liabilities | $349.94 | $368.9 | $343.7 | $265.06 |
| Total debt | $361.58 | $467.15 | $347.84 | $268.84 |
| Total liabilities | $403.25 | $505.29 | $395.49 | $301.79 |
| Shareholders' equity | ||||
| Retained earnings | -$753.53 | -$635.72 | -$683.13 | -$872.67 |
| Other shareholder equity | ||||
| Total shareholder equity | -$24.98 | $85.68 | $23.78 | -$120.75 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $45.35 | $26.77 | $28.89 | |
| Selling, general & administrative | $13.81 | $12.26 | $10.88 | |
| Total operating expenses | $59.16 | $39.03 | $39.77 | |
| Operating income | -$59.16 | -$39.03 | -$39.77 | |
| Income from continuing operations | ||||
| EBIT | -$46.83 | -$28.95 | -$2 | |
| Income tax expense | ||||
| Interest expense | $9.21 | $8.23 | $7.06 | |
| Net income | ||||
| Net income | -$56.04 | -$37.18 | -$9.07 | |
| Income (for common shares) | -$56.04 | -$37.18 | -$9.07 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $73.81 | |||
| Cost of revenue | $0.9 | |||
| Gross Profit | $72.91 | |||
| Operating activities | ||||
| Research & development | $114.87 | $112.72 | $118.78 | $110.82 |
| Selling, general & administrative | $49.66 | $50.67 | $54.84 | $72.69 |
| Total operating expenses | $164.53 | $163.39 | $173.62 | $183.51 |
| Operating income | -$164.53 | -$163.39 | -$173.62 | -$110.6 |
| Income from continuing operations | ||||
| EBIT | -$86.97 | $70.12 | $213.9 | -$123.32 |
| Income tax expense | -$12.01 | |||
| Interest expense | $30.84 | $22.7 | $19.67 | $26.75 |
| Net income | ||||
| Net income | -$117.81 | $47.42 | $194.24 | -$138.06 |
| Income (for common shares) | -$117.81 | $47.42 | $194.24 | -$138.06 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$56.04 | -$37.18 | -$9.07 | |
| Operating activities | ||||
| Depreciation | $0.21 | $0.2 | $0.2 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $2.77 | $2.66 | $2.69 | |
| Total cash flows from operations | -$45.98 | -$41.78 | -$34.83 | |
| Investing activities | ||||
| Capital expenditures | -$0.08 | -$0.06 | -$0.12 | |
| Investments | $73.23 | -$61.87 | $116.36 | |
| Total cash flows from investing | $47.26 | $73.15 | -$61.92 | $116.24 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0 | -$11.82 | -$4.65 | |
| Net borrowings | -$26.88 | $110.25 | -$100.3 | |
| Total cash flows from financing | $66.98 | -$26.88 | $98.43 | -$104.95 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$5.58 | $0.29 | -$5.27 | -$23.54 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$117.81 | $47.42 | $194.24 | -$138.06 |
| Operating activities | ||||
| Depreciation | $0.92 | $0.95 | $1.39 | $1.62 |
| Business acquisitions & disposals | $125.99 | |||
| Stock-based compensation | $11.65 | $14.07 | $17.63 | $14.93 |
| Total cash flows from operations | $74.73 | -$86.48 | -$109.72 | -$100.09 |
| Investing activities | ||||
| Capital expenditures | -$0.43 | -$0.11 | -$0.28 | -$0.28 |
| Investments | $27.88 | -$127.45 | $67.99 | -$66.75 |
| Total cash flows from investing | $27.45 | -$127.56 | $193.71 | -$67.03 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$4.5 | $0.41 | $8.38 | $98.7 |
| Net borrowings | -$101.58 | $123.83 | -$1.82 | $68.19 |
| Total cash flows from financing | -$106.08 | $124.25 | $6.32 | $174.53 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$3.9 | -$89.8 | $90.31 | $7.42 |
News
Fundamentals
| Market cap | $435.78M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 57.95M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | -16.14 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.96 |
| Quick ratio | N/A |